ACCSYS TECHNOLOGIES PLC (AXS.AS)

GB00BQQFX454 - Common Stock

0.641  0 (0%)

Fundamental Rating

3

Taking everything into account, AXS scores 3 out of 10 in our fundamental rating. AXS was compared to 10 industry peers in the Paper & Forest Products industry. Both the profitability and financial health of AXS have multiple concerns. While showing a medium growth rate, AXS is valued expensive at the moment.



3

1. Profitability

1.1 Basic Checks

AXS had negative earnings in the past year.
In the past year AXS had a positive cash flow from operations.
In multiple years AXS reported negative net income over the last 5 years.
AXS had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -12.53%, AXS is doing worse than 88.89% of the companies in the same industry.
AXS has a worse Return On Equity (-23.78%) than 88.89% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.21%, AXS is doing worse than 66.67% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AXS is below the industry average of 7.49%.
The last Return On Invested Capital (5.21%) for AXS is above the 3 year average (3.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -12.53%
ROE -23.78%
ROIC 5.21%
ROA(3y)-5.39%
ROA(5y)-3.77%
ROE(3y)-9.9%
ROE(5y)-8.12%
ROIC(3y)3.17%
ROIC(5y)N/A

1.3 Margins

AXS has a worse Operating Margin (6.75%) than 66.67% of its industry peers.
AXS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 32.90%, AXS is doing worse than 66.67% of the companies in the same industry.
In the last couple of years the Gross Margin of AXS has grown nicely.
Industry RankSector Rank
OM 6.75%
PM (TTM) N/A
GM 32.9%
OM growth 3Y84.6%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.01%
GM growth 5Y8.74%

2

2. Health

2.1 Basic Checks

AXS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AXS has more shares outstanding
AXS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AXS has a worse debt to assets ratio.

2.2 Solvency

AXS has an Altman-Z score of 1.10. This is a bad value and indicates that AXS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.10, AXS is doing worse than 88.89% of the companies in the same industry.
AXS has a debt to FCF ratio of 6.95. This is a slightly negative value and a sign of low solvency as AXS would need 6.95 years to pay back of all of its debts.
AXS has a Debt to FCF ratio (6.95) which is in line with its industry peers.
AXS has a Debt/Equity ratio of 0.54. This is a neutral value indicating AXS is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.54, AXS perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 6.95
Altman-Z 1.1
ROIC/WACC0.76
WACC6.86%

2.3 Liquidity

AXS has a Current Ratio of 1.74. This is a normal value and indicates that AXS is financially healthy and should not expect problems in meeting its short term obligations.
AXS has a Current ratio of 1.74. This is comparable to the rest of the industry: AXS outperforms 55.56% of its industry peers.
AXS has a Quick Ratio of 1.74. This is a bad value and indicates that AXS is not financially healthy enough and could expect problems in meeting its short term obligations.
AXS has a worse Quick ratio (0.91) than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.74
Quick Ratio 0.91

5

3. Growth

3.1 Past

The earnings per share for AXS have decreased by -0.56% in the last year.
Looking at the last year, AXS shows a very strong growth in Revenue. The Revenue has grown by 41.17%.
Measured over the past years, AXS shows a very strong growth in Revenue. The Revenue has been growing by 21.61% on average per year.
EPS 1Y (TTM)-0.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%52.4%
Revenue 1Y (TTM)41.17%
Revenue growth 3Y21.24%
Revenue growth 5Y21.61%
Sales Q2Q%20.93%

3.2 Future

AXS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.18% yearly.
Based on estimates for the next years, AXS will show a small growth in Revenue. The Revenue will grow by 2.79% on average per year.
EPS Next Y-41.59%
EPS Next 2Y-75.16%
EPS Next 3Y15.18%
EPS Next 5YN/A
Revenue Next Year-7.33%
Revenue Next 2Y-4.46%
Revenue Next 3Y-0.24%
Revenue Next 5Y2.79%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

AXS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AXS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

AXS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AXS is cheaper than 66.67% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXS indicates a somewhat cheap valuation: AXS is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 15.44
EV/EBITDA 9.44

4.3 Compensation for Growth

A more expensive valuation may be justified as AXS's earnings are expected to grow with 15.18% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-75.16%
EPS Next 3Y15.18%

0

5. Dividend

5.1 Amount

AXS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACCSYS TECHNOLOGIES PLC

AMS:AXS (7/26/2024, 7:00:00 PM)

0.641

0 (0%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap153.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.53%
ROE -23.78%
ROCE
ROIC
ROICexc
ROICexgc
OM 6.75%
PM (TTM) N/A
GM 32.9%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.74
Quick Ratio 0.91
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-0.56%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y-41.59%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)41.17%
Revenue growth 3Y21.24%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y